AU5521099A - Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis - Google Patents
Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitisInfo
- Publication number
- AU5521099A AU5521099A AU55210/99A AU5521099A AU5521099A AU 5521099 A AU5521099 A AU 5521099A AU 55210/99 A AU55210/99 A AU 55210/99A AU 5521099 A AU5521099 A AU 5521099A AU 5521099 A AU5521099 A AU 5521099A
- Authority
- AU
- Australia
- Prior art keywords
- seborrheic dermatitis
- medicine
- making
- treating herpes
- lithium gluconate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention concerns the therapeutic use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis, preferably in a composition designed for topical administration, the lithium gluconate content ranging between 1 and 50 wt. % relative to the composition total weight. The invention is useful for treating herpes and seborrheic dermatitis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9811025A FR2783424B1 (en) | 1998-09-03 | 1998-09-03 | USE OF LITHIUM GLUCONATE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HERPES AND SEBORRHEIC DERMITIS |
FR9811025 | 1998-09-03 | ||
PCT/FR1999/002108 WO2000013649A2 (en) | 1998-09-03 | 1999-09-03 | Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5521099A true AU5521099A (en) | 2000-03-27 |
Family
ID=9530089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55210/99A Abandoned AU5521099A (en) | 1998-09-03 | 1999-09-03 | Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1107766B1 (en) |
AT (1) | ATE234620T1 (en) |
AU (1) | AU5521099A (en) |
CA (1) | CA2341566C (en) |
DE (1) | DE69906091T2 (en) |
ES (1) | ES2193741T3 (en) |
FR (1) | FR2783424B1 (en) |
PT (1) | PT1107766E (en) |
WO (1) | WO2000013649A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416981B1 (en) | 2000-05-23 | 2002-07-09 | Nec Partnership | Production of gluconate salts |
EP1948236B1 (en) * | 2005-09-27 | 2021-03-03 | Special Water Patents B.V. | Methods and compositions for treatment of skin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8318912D0 (en) * | 1983-07-13 | 1983-08-17 | Horrobin D F | Compositions for treatment of skin/hair |
GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
CA2158137C (en) * | 1993-03-12 | 2004-03-02 | James Derek Birchall | Therapeutic compositions containing a lithium compound and silica |
-
1998
- 1998-09-03 FR FR9811025A patent/FR2783424B1/en not_active Expired - Fee Related
-
1999
- 1999-09-03 CA CA002341566A patent/CA2341566C/en not_active Expired - Fee Related
- 1999-09-03 PT PT99941691T patent/PT1107766E/en unknown
- 1999-09-03 AT AT99941691T patent/ATE234620T1/en active
- 1999-09-03 WO PCT/FR1999/002108 patent/WO2000013649A2/en active IP Right Grant
- 1999-09-03 EP EP99941691A patent/EP1107766B1/en not_active Expired - Lifetime
- 1999-09-03 AU AU55210/99A patent/AU5521099A/en not_active Abandoned
- 1999-09-03 ES ES99941691T patent/ES2193741T3/en not_active Expired - Lifetime
- 1999-09-03 DE DE69906091T patent/DE69906091T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2783424B1 (en) | 2002-10-04 |
EP1107766B1 (en) | 2003-03-19 |
ATE234620T1 (en) | 2003-04-15 |
DE69906091T2 (en) | 2003-11-20 |
PT1107766E (en) | 2003-08-29 |
ES2193741T3 (en) | 2003-11-01 |
WO2000013649A2 (en) | 2000-03-16 |
EP1107766A2 (en) | 2001-06-20 |
WO2000013649A3 (en) | 2000-07-20 |
FR2783424A1 (en) | 2000-03-24 |
CA2341566A1 (en) | 2000-03-16 |
CA2341566C (en) | 2009-11-24 |
DE69906091D1 (en) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3168395A (en) | Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof | |
WO2003024387A3 (en) | Method and pharmaceutical composition for treating inflammation | |
MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
RO116342B1 (en) | Oral liquid pharmaceutical composition | |
MY132705A (en) | Novel compounds with analgesic effect | |
AU2002216748A1 (en) | Method of treatment of seborrheic dermatitis | |
WO1995031991A3 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
CA2158036A1 (en) | 3,4-Diarylchromans for Treatment of Dermatitis | |
WO1999061010A3 (en) | Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound | |
NZ326345A (en) | Composition containing diosgenin | |
AU5521099A (en) | Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis | |
AU1400895A (en) | 2,3-diaryl-1-benzopyrans for treating dermatitis | |
IL112019A (en) | Pharmaceutical compositions for topical treatment of psoriasis | |
GB2353214A (en) | Topical Composition | |
RO116345B1 (en) | Analgesic vegetable composition | |
IT1264428B1 (en) | Pharmaceutical compositions for the treatment of psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |